Hyperlipoproteinemia type I in a patient with active lipoprotein lipase in adipose tissue and indications of defective transport of the enzyme.
This paper presents a case of typical hyperlipoproteinemia type I in a young woman. Her serum triglycerides varied between 2 and 90 mmol/l and she had substantial amounts of apolipoprotein B-48 in fasting plasma. She had no detectable lipoprotein lipase (LPL) activity in post-heparin plasma (less than 0.2 percent of normal). Southern blot analysis suggested no major defect in her LPL gene and Northern blot analysis of adipose tissue RNA showed normal-sized LPL-mRNA. A 2-h [35S]methionine incorporation experiment with adipose tissue pieces in vitro showed that she produced normal-sized LPL and had LPL catalytic activity in the tissue. The amounts were, however, only 5-10% of control. No detectable LPL radioactivity or catalytic activity was released from patient tissue even in the presence of heparin in the incubations. Immunofluorescent staining of adipose tissue biopsies from the patient showed LPL immunoreactivity only in adipocytes and little or none within the capillaries. Treatment of immunoprecipitated labeled LPL with endoglycosidase H showed that the oligosaccharide chains on her enzyme were of the high-mannose type and not processed as in controls. Taken together the data suggest that the patient synthesizes a relatively normal LPL protein which is core-glycosylated and folded into active enzyme as in normal subjects, but is not effectively transported via the Golgi to the cell surface.
Fager
G
G
Arterial Biology Group, Wallenberg Laboratory for Cardiovascular Research, Göteborg, Sweden.
Semb
H
H
Enerbäck
S
S
Olivecrona
T
T
Jonasson
L
L
Bengtsson-Olivecrona
G
G
Camejo
G
G
Bjursell
G
G
Bondjers
G
G
D000273:Adipose Tissue / Q000201:enzymology*; D000328:Adult; D001692:Biological Transport; D015152:Blotting, Northern; D015139:Blotting, Southern; D004041:Dietary Fats / Q000008:administration & dosage; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D005455:Fluorescent Antibody Technique; D005796:Genes; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D008072:Hyperlipoproteinemia Type I / Q000201:enzymology*; D006951:Hyperlipoproteinemias / Q000201:enzymology*; D008071:Lipoprotein Lipase / Q000235:genetics / Q000378:metabolism*; D011233:Precipitin Tests; D014280:Triglycerides / Q000097:blood
D004041:Dietary Fats; D014280:Triglycerides; D006493:Heparin; D008071:Lipoprotein Lipase